A novel oncolytic herpes simplex virus type 2 has potent anti-tumor activity - Wikidata - wikimedia - TriplyDB

A novel oncolytic herpes simplex virus type 2 has potent anti-tumor activity

A novel oncolytic herpes simplex virus type 2 has potent anti-tumor activity

http://www.wikidata.org/entity/Q35132272

about

Promising oncolytic agents for metastatic breast cancer treatment Cancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advances Emerging role of Natural killer cells in oncolytic virotherapy High efficiency of alphaviral gene transfer in combination with 5-fluorouracil in a mouse mammary tumor model.Antitumor effects of oncolytic herpes simplex virus type 2 against colorectal cancer in vitro and in vivo.Treatment of colon cancer with oncolytic herpes simplex virus in preclinical models.Oncolytic Immunotherapy for Treatment of Cancer.

P2860

Q26830620-F1D25C4C-F95C-4FE0-974C-69447C24A6F8 Q26863779-38AE3EE0-5741-43BC-9C2C-0D52979FC1D8 Q27025330-0C1B974A-97E0-4B6D-80A1-B13D7CE763D6 Q33828697-23AE5F7E-8776-44DA-9451-19AD3BCF19B1 Q37641458-ED5903DC-9FD5-40A8-BC0A-090EEB933BF0 Q38794655-0815EC81-813D-4212-991A-C51B45429526 Q38848223-6498525E-38C0-403D-9632-C75E8FD8A653

P2860

A novel oncolytic herpes simplex virus type 2 has potent anti-tumor activity

http://www.wikidata.org/entity/Q35132272

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

A novel oncolytic herpes simplex virus type 2 has potent anti-tumor activity

@ast

A novel oncolytic herpes simplex virus type 2 has potent anti-tumor activity

@en

type

label

A novel oncolytic herpes simplex virus type 2 has potent anti-tumor activity

@ast

A novel oncolytic herpes simplex virus type 2 has potent anti-tumor activity

@en

prefLabel

A novel oncolytic herpes simplex virus type 2 has potent anti-tumor activity

@ast

A novel oncolytic herpes simplex virus type 2 has potent anti-tumor activity

@en

P1433

Q35132272-76A11F21-B50F-485A-90D8-4B409FD92224

P1476

Q35132272-E1F940A5-B6FB-4383-9C00-BCE883DFA1DE

P2093

Q35132272-09C5F2D1-6865-49C1-AFE0-49803A946A2E

Q35132272-3C139C96-BBBB-476F-8FBB-54834EBC97F4

Q35132272-61E3849A-D116-4692-80A8-9FF8583CA53A

Q35132272-6C55D320-4D75-4939-8500-875CE0B7CE20

Q35132272-79125DB4-1D44-4C5E-87AB-0C39D86ADCB3

Q35132272-8E2CD1AA-BA28-46F4-BF29-73EEFA1AD6D0

Q35132272-901A84B6-5DBB-4504-8A5B-F5C493847565

Q35132272-91E994FE-AB9F-46E8-B8F3-C9D6FEDEA22D

Q35132272-945203CA-7B77-4CA9-9DCA-3E3431325892

Q35132272-D04FBB91-1BD7-4AA7-BF57-9E9584FCE1CE

P2860

Q35132272-0B1FC56F-3814-40F0-831C-E4A0A3D9C26F

Q35132272-0D6735D3-70C4-4933-A914-346E0E603112

Q35132272-0E915AD8-8F85-477A-A411-354F216B86CC

Q35132272-1555E39E-7149-487A-A971-2B2F53D4C696

Q35132272-2B54CB9B-BF9D-4B25-8477-5017D84CE2EB

Q35132272-378BE505-D2D9-47E5-A423-DB27AC14B962

Q35132272-3C9177C7-B497-485B-81D5-990E7FD9E529

Q35132272-41FF4F65-E609-4260-BEF4-070B2E18FB7C

Q35132272-4C5F9A28-AEDB-4E67-989F-0926B0D0B84A

Q35132272-57BCA78E-5B73-42F8-BD3C-3CE5E4D0D4D4

P304

Q35132272-B6F17DA0-D9C0-45B1-83AE-983B0D57E0D3

P31

Q35132272-0ED95D25-2DFA-42C9-ADCC-C68A0DC1657B

P356

Q35132272-FA3A2679-8C2F-4E63-9EA9-01E1EC20F21D

P407

Q35132272-752A7A09-79C6-4BA2-96CF-6851C1475499

P433

Q35132272-A19070B1-B536-49DB-B345-6748381C1B3F

P478

Q35132272-2503B720-CD06-4D0D-9899-CB615EF813DE

P577

Q35132272-3D3E3777-413F-4CCE-A1BD-1B2CA68BCEBF

P5875

Q35132272-1286ACD0-0CE4-4C8A-8A38-707B22AE03DE

P698

Q35132272-319EBC17-BE6C-4225-9847-6D6BF3A2C587

P921

Q35132272-CB29EB4D-93CE-4E2A-B72C-0755254BE29B

P932

Q35132272-E70BC09F-50BD-474C-8B17-ADDA0E7994D6

P356

JOURNAL.PONE.0093103

P1433

P1476

A novel oncolytic herpes simplex virus type 2 has potent anti-tumor activity

@en

P2093

Binlei Liu

http://www.w3.org/2001/XMLSchema#string

Haizhen Lu

http://www.w3.org/2001/XMLSchema#string

Jie Li

http://www.w3.org/2001/XMLSchema#string

Jing Liang

http://www.w3.org/2001/XMLSchema#string

Qian Zhao

http://www.w3.org/2001/XMLSchema#string

Shangmei Liu

http://www.w3.org/2001/XMLSchema#string

Shuren Zhang

http://www.w3.org/2001/XMLSchema#string

Wen Zhang

http://www.w3.org/2001/XMLSchema#string

Xiufen Zhuang

http://www.w3.org/2001/XMLSchema#string

Ying Dong

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer cell death enhances the penetration and efficacy of oncolytic herpes simplex virus in tumors

Enhanced antitumor efficacy of vasculostatin (Vstat120) expressing oncolytic HSV-1.

Biological approaches to therapy of pancreatic cancer.

Effect of adriamycin on DNA, RNA, and protein synthesis in cell-free systems and intact cells.

Activated MEK suppresses activation of PKR and enables efficient replication and in vivo oncolysis by Deltagamma(1)34.5 mutants of herpes simplex virus 1

Interference by doxorubicin with DNA unwinding in MCF-7 breast tumor cells.

Doxorubicin-enriched, ALDH(br) mouse breast cancer stem cells are treatable to oncolytic herpes simplex virus type 1

A phase I study of OncoVEXGM-CSF, a second-generation oncolytic herpes simplex virus expressing granulocyte macrophage colony-stimulating factor.

Gene therapy for cancer treatment: past, present and future

Lymphokine-activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascites

P304

e93103

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0093103

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2014-03-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261138554

http://www.w3.org/2001/XMLSchema#string

P698

24671154

http://www.w3.org/2001/XMLSchema#string

P921

oncolytic virus

P932

3966855

http://www.w3.org/2001/XMLSchema#string